[{"address1": "105 Bradford Road", "address2": "Suite 420", "city": "Wexford", "state": "PA", "zip": "15090", "country": "United States", "phone": "(724) 934-6467", "website": "https://coeptistx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. David  Mehalick", "age": 54, "title": "Co-Founder, Chairman of the Board, CEO & President", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Christine Elise Sheehy", "age": 55, "title": "Co-Founder and VP of Compliance & Corporate Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 150999, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel Alexander Yerace", "age": 40, "title": "Co-Founder, VP of Operations & Director", "yearBorn": 1983, "fiscalYear": 2023, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Cogley M.B.A.", "age": 36, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 208000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Colleen  Delaney M.D., M.Sc.", "age": 55, "title": "CSO & Chief Medical Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.2675, "open": 0.2675, "dayLow": 0.2632, "dayHigh": 0.287, "regularMarketPreviousClose": 0.2675, "regularMarketOpen": 0.2675, "regularMarketDayLow": 0.2632, "regularMarketDayHigh": 0.287, "beta": -0.934, "forwardPE": -0.5401923, "volume": 200678, "regularMarketVolume": 200678, "averageVolume": 503873, "averageVolume10days": 389370, "averageDailyVolume10Day": 389370, "bid": 0.2767, "ask": 0.2815, "bidSize": 100, "askSize": 100, "marketCap": 10426615, "fiftyTwoWeekLow": 0.23, "fiftyTwoWeekHigh": 1.87, "fiftyDayAverage": 0.33312, "twoHundredDayAverage": 0.720365, "currency": "USD", "enterpriseValue": 11825009, "floatShares": 21726626, "sharesOutstanding": 37118600, "sharesShort": 76566, "sharesShortPriorMonth": 174308, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0021, "heldPercentInsiders": 0.31641, "heldPercentInstitutions": 0.12781, "shortRatio": 0.59, "shortPercentOfFloat": 0.0023999999, "impliedSharesOutstanding": 37118600, "bookValue": 0.12, "priceToBook": 2.3408334, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -16310092, "trailingEps": -0.51, "forwardEps": -0.52, "enterpriseToEbitda": -0.701, "52WeekChange": -0.82437503, "SandP52WeekChange": 0.23232913, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "COEP", "underlyingSymbol": "COEP", "shortName": "Coeptis Therapeutics Holdings, ", "longName": "Coeptis Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1608215400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "820436ab-e838-3404-bbe6-691814b0374c", "messageBoardId": "finmb_593091629", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.2809, "targetHighPrice": 3.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.0, "targetMedianPrice": 3.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 1029244, "totalCashPerShare": 0.028, "ebitda": -16873418, "totalDebt": 2427640, "quickRatio": 0.265, "currentRatio": 1.599, "debtToEquity": 55.688, "returnOnAssets": -1.4568499, "returnOnEquity": -5.77823, "freeCashflow": -9317908, "operatingCashflow": -7457434, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-10"}]